Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial.
Soleimani D, Rezaie M, Rajabzadeh F, Gholizadeh Navashenaq J, Abbaspour M, Miryan M, Razmpour F, Ranjbar G, Rezvani R, Jarahi L, Hashemy SI, Goshayeshi L, Nematy M. Soleimani D, et al. Among authors: abbaspour m. Phytother Res. 2021 Mar;35(3):1669-1679. doi: 10.1002/ptr.6937. Epub 2020 Nov 9. Phytother Res. 2021. PMID: 33166032 Clinical Trial.
The effects of propolis supplementation on high-sensitivity C-reactive protein, testosterone hormone, and metabolic profile in women with polycystic ovary syndrome: A randomized, triple-blinded, placebo-controlled clinical trial.
Abbasi E, Bagherniya M, Soleimani D, Ghasemi-Tehrani H, Abbaspour M, Clark CCT, Askari G. Abbasi E, et al. Among authors: abbaspour m. Phytother Res. 2023 Nov;37(11):5366-5377. doi: 10.1002/ptr.7977. Epub 2023 Sep 2. Phytother Res. 2023. PMID: 37658679 Clinical Trial.
Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial.
Vazirian F, Samadi S, Abbaspour M, Taleb A, Bagherhosseini H, Mozaffari HM, Mohammadpour AH, Emami SA. Vazirian F, et al. Among authors: abbaspour m. Inflammopharmacology. 2022 Dec;30(6):2145-2152. doi: 10.1007/s10787-022-00991-3. Epub 2022 Jun 20. Inflammopharmacology. 2022. PMID: 35723850 Clinical Trial.
A randomized, double-blind placebo-controlled add-on trial to assess the efficacy, safety, and anti-atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus.
Karizi SR, Armanmehr F, Azadi HG, Zahroodi HS, Ghalibaf AM, Bazzaz BSF, Abbaspour M, Boskabadi J, Eslami S, Taherzadeh Z. Karizi SR, et al. Among authors: abbaspour m. Phytother Res. 2023 Apr;37(4):1435-1448. doi: 10.1002/ptr.7674. Epub 2023 Jan 4. Phytother Res. 2023. PMID: 36598187 Clinical Trial.
108 results